Ross Thomas M. has filed 59 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 15476 shares of MAXCYTE, INC. ($MXCT) on August 01, 2024.
Activity breakdown: 0 open-market purchases and 18 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 1, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Common Stock | 15476 | $1.64 | 40,476.0000 | 104,639,239 | 61.90% | 0.01% |
| Aug. 1, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | S | Common Stock | 15476 | $4.54 | 25,000.0000 | 104,639,239 | 38.24% | 0.01% |
| Aug. 2, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Common Stock | 17857 | $1.64 | 42,857.0000 | 104,639,239 | 71.43% | 0.02% |
| Aug. 2, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | S | Common Stock | 17857 | $4.36 | 25,000.0000 | 104,639,239 | 41.67% | 0.02% |
| Aug. 1, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Employee Stock Option (right to buy) | 15476 | $0.00 | 17,858.0000 | 104,639,239 | 46.43% | 0.01% |
| Aug. 2, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Employee Stock Option (right to buy) | 17857 | $0.00 | 1.0000 | 104,639,239 | 99.99% | 0.02% |
| July 8, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Common Stock | 19802 | $1.64 | 44,802.0000 | 104,639,239 | 79.21% | 0.02% |
| July 8, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | S | Common Stock | 19802 | $4.03 | 25,000.0000 | 104,639,239 | 44.20% | 0.02% |
| July 9, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Common Stock | 13531 | $1.64 | 38,531.0000 | 104,639,239 | 54.12% | 0.01% |
| July 9, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | S | Common Stock | 13531 | $4.03 | 25,000.0000 | 104,639,239 | 35.12% | 0.01% |
| July 8, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Employee Stock Option (right to buy) | 19802 | $0.00 | 46,865.0000 | 104,639,239 | 29.70% | 0.02% |
| July 9, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Employee Stock Option (right to buy) | 13531 | $0.00 | 33,334.0000 | 104,639,239 | 28.87% | 0.01% |
| June 20, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Common Stock | 33333 | $1.64 | 58,333.0000 | 104,089,758 | 133.33% | 0.03% |
| June 20, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | S | Common Stock | 33333 | $4.09 | 25,000.0000 | 104,089,758 | 57.14% | 0.03% |
| June 20, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES | M | Employee Stock Option (right to buy) | 33333 | $0.00 | 66,667.0000 | 104,089,758 | 33.33% | 0.03% |
| March 15, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES & MARKETING | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 103,268,502 | 9999.99% | 0.02% |
| March 15, 2024 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, GLOBAL SALES & MARKETING | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 103,268,502 | 9999.99% | 0.10% |
| April 10, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 100 | $2.14 | 100.0000 | 102,846,036 | 9999.99% | 0.00% |
| April 10, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 100 | $5.00 | 0.0000 | 102,846,036 | 100.00% | 0.00% |
| April 11, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 8451 | $2.14 | 8,451.0000 | 102,846,036 | 9999.99% | 0.01% |
| April 11, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 8451 | $5.00 | 0.0000 | 102,846,036 | 100.00% | 0.01% |
| April 12, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 5583 | $2.14 | 5,583.0000 | 102,846,036 | 9999.99% | 0.01% |
| April 12, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 5583 | $5.00 | 0.0000 | 102,846,036 | 100.00% | 0.01% |
| April 10, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 100 | $0.00 | 27,902.0000 | 102,846,036 | 0.36% | 0.00% |
| April 11, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 8451 | $0.00 | 19,451.0000 | 102,846,036 | 30.29% | 0.01% |
| April 12, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 5583 | $0.00 | 13,868.0000 | 102,846,036 | 28.70% | 0.01% |
| April 5, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 6967 | $2.14 | 6,967.0000 | 102,846,036 | 9999.99% | 0.01% |
| April 5, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 6967 | $5.00 | 0.0000 | 102,846,036 | 100.00% | 0.01% |
| April 6, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 27193 | $2.14 | 27,193.0000 | 102,846,036 | 9999.99% | 0.03% |
| April 6, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 27193 | $5.03 | 0.0000 | 102,846,036 | 100.00% | 0.03% |
| April 5, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 6967 | $0.00 | 55,195.0000 | 102,846,036 | 11.21% | 0.01% |
| April 6, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 27193 | $0.00 | 28,002.0000 | 102,846,036 | 49.27% | 0.03% |
| March 31, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 2607 | $2.14 | 2,607.0000 | 101,702,664 | 9999.99% | 0.00% |
| March 31, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 2607 | $5.00 | 0.0000 | 101,702,664 | 100.00% | 0.00% |
| April 3, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 100 | $2.14 | 100.0000 | 102,846,036 | 9999.99% | 0.00% |
| April 3, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 100 | $5.01 | 0.0000 | 102,846,036 | 100.00% | 0.00% |
| April 4, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 7266 | $2.14 | 7,266.0000 | 102,846,036 | 9999.99% | 0.01% |
| April 4, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 7266 | $5.03 | 0.0000 | 102,846,036 | 100.00% | 0.01% |
| March 31, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 2607 | $0.00 | 69,528.0000 | 101,702,664 | 3.61% | 0.00% |
| April 3, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 100 | $0.00 | 69,428.0000 | 102,846,036 | 0.14% | 0.00% |
| April 4, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 7266 | $0.00 | 62,162.0000 | 102,846,036 | 10.47% | 0.01% |
| March 20, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 101,702,664 | 9999.99% | 0.12% |
| Feb. 1, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 2468 | $0.98 | 2,468.0000 | 101,702,664 | 9999.99% | 0.00% |
| Feb. 1, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 15090 | $2.14 | 17,558.0000 | 101,702,664 | 611.43% | 0.01% |
| Feb. 1, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 17558 | $5.68 | 0.0000 | 101,702,664 | 100.00% | 0.02% |
| Feb. 2, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 11575 | $2.14 | 11,575.0000 | 101,702,664 | 9999.99% | 0.01% |
| Feb. 2, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 11575 | $5.77 | 0.0000 | 101,702,664 | 100.00% | 0.01% |
| Feb. 1, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 2468 | $0.00 | 0.0000 | 101,702,664 | 100.00% | 0.00% |
| Feb. 1, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 15090 | $0.00 | 83,710.0000 | 101,702,664 | 15.27% | 0.01% |
| Feb. 2, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 11575 | $0.00 | 72,135.0000 | 101,702,664 | 13.83% | 0.01% |
| Jan. 3, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 10513 | $0.98 | 10,513.0000 | 101,702,664 | 9999.99% | 0.01% |
| Jan. 3, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 10513 | $5.13 | 0.0000 | 101,702,664 | 100.00% | 0.01% |
| Jan. 4, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 9153 | $0.98 | 9,153.0000 | 101,702,664 | 9999.99% | 0.01% |
| Jan. 4, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 9153 | $5.07 | 0.0000 | 101,702,664 | 100.00% | 0.01% |
| Jan. 5, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Common Stock | 9467 | $0.98 | 9,467.0000 | 101,702,664 | 9999.99% | 0.01% |
| Jan. 5, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | S | Common Stock | 9467 | $5.04 | 0.0000 | 101,702,664 | 100.00% | 0.01% |
| Jan. 3, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 10513 | $0.00 | 21,088.0000 | 101,702,664 | 33.27% | 0.01% |
| Jan. 4, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 9153 | $0.00 | 11,935.0000 | 101,702,664 | 43.40% | 0.01% |
| Jan. 5, 2023 | MAXCYTE, INC. | $MXCT | Ross Thomas M. | EVP, Global Sales & Marketing | M | Employee Stock Option (right to buy) | 9467 | $0.00 | 2,468.0000 | 101,702,664 | 79.32% | 0.01% |